Let it flow

Innovative solutions with small-scale microfluidics.

By | January 1, 2008

Microfluidics has so far been used in mostly large-scale, automated pharma and biotech projects, such as nucleic acid and protein separation. Miniaturizing fluid flow to the micrometer-to-millimeter scale offers plenty of advantages for studying cells and small organisms. Biologic-scale microfluidic devices can mimic many in vivo situations, such as laminar blood flow through a capillary or the three-dimensional structures that culture plates can't capture. Such systems can also help researchers to use scarce primary cells and expensive reagents more efficiently.

Already, at least two companies, Cellix and Agilent, offer systems for specific cellular applications, and others are working on prototypes. Their price tags (about $100,000 or more), though, put them out of the reach of most academic labs. So, researchers are starting to collaborate with companies or academic engineers, or are bringing engineers into their own labs, to design smart, small-scale solutions for cellular studies. It's no simple task, however. If you're thinking of designing your own system, you might go through several iterations before you have a working assay. The Scientist asked researchers who have done the tinkering to describe the steps they took to perfect their designs, so you can learn from their experiences.

Click on any of the case studies in the box to the right to read about their experiences.

Comments

Avatar of: Knut Wintergerst

Knut Wintergerst

Posts: 1

January 16, 2008

The price tag for a 2100 Bioanalyzer Flow Cytometry system, which includes everything apart from the consumables, is in the order of $25-30k. It can be easily expanded, but just swapping a cartridge, to also run electrophoresis applications (RNA, DNA, Protein).
Avatar of: Richard Parker

Richard Parker

Posts: 2

January 17, 2008

build your own microfluidic system with these parts\nhttp://www.parker.com/ead/cm2.asp?cmid=10999

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS